1. Home
  2. RXRX vs PCT Comparison

RXRX vs PCT Comparison

Compare RXRX & PCT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • RXRX
  • PCT
  • Stock Information
  • Founded
  • RXRX 2013
  • PCT 2015
  • Country
  • RXRX United States
  • PCT United States
  • Employees
  • RXRX N/A
  • PCT N/A
  • Industry
  • RXRX Biotechnology: Pharmaceutical Preparations
  • PCT Environmental Services
  • Sector
  • RXRX Health Care
  • PCT Utilities
  • Exchange
  • RXRX Nasdaq
  • PCT Nasdaq
  • Market Cap
  • RXRX 2.0B
  • PCT 2.4B
  • IPO Year
  • RXRX 2021
  • PCT N/A
  • Fundamental
  • Price
  • RXRX $6.40
  • PCT $12.87
  • Analyst Decision
  • RXRX Buy
  • PCT Buy
  • Analyst Count
  • RXRX 6
  • PCT 6
  • Target Price
  • RXRX $9.40
  • PCT $7.70
  • AVG Volume (30 Days)
  • RXRX 3.9M
  • PCT 3.1M
  • Earning Date
  • RXRX 11-06-2024
  • PCT 11-07-2024
  • Dividend Yield
  • RXRX N/A
  • PCT N/A
  • EPS Growth
  • RXRX N/A
  • PCT N/A
  • EPS
  • RXRX N/A
  • PCT N/A
  • Revenue
  • RXRX $49,635,000.00
  • PCT N/A
  • Revenue This Year
  • RXRX $58.36
  • PCT N/A
  • Revenue Next Year
  • RXRX $31.15
  • PCT $494.98
  • P/E Ratio
  • RXRX N/A
  • PCT N/A
  • Revenue Growth
  • RXRX N/A
  • PCT N/A
  • 52 Week Low
  • RXRX $5.04
  • PCT $2.39
  • 52 Week High
  • RXRX $15.74
  • PCT $15.58
  • Technical
  • Relative Strength Index (RSI)
  • RXRX 46.48
  • PCT 65.45
  • Support Level
  • RXRX $6.32
  • PCT $12.73
  • Resistance Level
  • RXRX $6.90
  • PCT $15.58
  • Average True Range (ATR)
  • RXRX 0.33
  • PCT 1.05
  • MACD
  • RXRX -0.01
  • PCT 0.11
  • Stochastic Oscillator
  • RXRX 22.65
  • PCT 57.77

About RXRX Recursion Pharmaceuticals Inc.

Recursion Pharmaceuticals Inc is a clinical-stage biotechnology company. It is decoding biology by integrating technological innovations across biology, chemistry, automation, data science, and engineering, with the goal of radically improving the lives of patients and industrializing drug discovery.

About PCT PureCycle Technologies Inc. Common stock

PureCycle Technologies Inc holds a license to commercialize the only patented solvent-based purification recycling technology, developed by The Procter & Gamble Company (P&G), for restoring waste polypropylene (PP) into a virgin-like resin. The proprietary process removes color, odor, and other contaminants from recycled feedstock resulting in virgin-like polypropylene suitable for any PP market.

Share on Social Networks: